A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: A RTOG randomized study (#79-04)

Ding-Jen Lee, Thomas F. Pajak, Joanne Stetz, Stanley E. Order, Joseph B. Weissberg, James J. Fischer

International Journal of Radiation Oncology*Biology*Physics · 1989 · 42 citations · 21 references

Concepts

References

21